These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 18590343)

  • 1. Use of second-generation antiepileptic drugs in the pediatric population.
    Chung AM; Eiland LS
    Paediatr Drugs; 2008; 10(4):217-54. PubMed ID: 18590343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiepileptic drugs in North America].
    Akiyama T; Otsubo H
    Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
    Patsalos PN; Sander JW
    Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
    Neurology; 2004 Apr; 62(8):1261-73. PubMed ID: 15111660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new look at the second-generation antiepileptic drugs: a decade of experience.
    LaRoche SM
    Neurologist; 2007 May; 13(3):133-9. PubMed ID: 17495757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer antiepileptic drugs: advantages and disadvantages.
    Wallace SJ
    Brain Dev; 2001 Aug; 23(5):277-83. PubMed ID: 11504596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
    Neurology; 2004 Apr; 62(8):1252-60. PubMed ID: 15111659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Newer antiepileptic drugs].
    Matsuura M
    No To Shinkei; 2007 Feb; 59(2):147-56. PubMed ID: 17315756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some common issues in the use of antiepileptic drugs.
    Asconapé JJ
    Semin Neurol; 2002 Mar; 22(1):27-39. PubMed ID: 12170391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new antiepileptic drugs: pharmacological and clinical aspects.
    Gatti G; Bonomi I; Jannuzzi G; Perucca E
    Curr Pharm Des; 2000 May; 6(8):839-60. PubMed ID: 10828310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of add-on therapy with newer-generation antiepileptic drugs in Bulgarian patients with refractory epilepsy.
    Viteva E; Zahariev Z
    Epilepsy Behav; 2018 Oct; 87():137-145. PubMed ID: 30097339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antiepileptic drugs: a systematic review of their efficacy and tolerability.
    Marson AG; Kadir ZA; Chadwick DW
    BMJ; 1996 Nov; 313(7066):1169-74. PubMed ID: 8916746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Newer antiepileptic drugs].
    Matsuura M
    Brain Nerve; 2007 Feb; 59(2):147-56. PubMed ID: 17380779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new generation of antiepileptic drugs: advantages and disadvantages.
    Perucca E
    Br J Clin Pharmacol; 1996 Nov; 42(5):531-43. PubMed ID: 8951184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines.
    Beghi E
    Lancet Neurol; 2004 Oct; 3(10):618-21. PubMed ID: 15380158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Llanas Park E; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J
    Neurology; 2018 Jul; 91(2):74-81. PubMed ID: 29898971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection criteria for the clinical use of the newer antiepileptic drugs.
    Deckers CL; Knoester PD; de Haan GJ; Keyser A; Renier WO; Hekster YA
    CNS Drugs; 2003; 17(6):405-21. PubMed ID: 12697000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antiepileptic drug therapies.
    Bergin AM; Connolly M
    Neurol Clin; 2002 Nov; 20(4):1163-82. PubMed ID: 12616686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interactions involving the new second- and third-generation antiepileptic drugs.
    Johannessen Landmark C; Patsalos PN
    Expert Rev Neurother; 2010 Jan; 10(1):119-40. PubMed ID: 20021326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.